FACIT Features: Fusion Pharma Attracts $20M USD Commitment from Canada Pension Plan Investment Board

January 13, 2020 – January 13, 2020 – The financing enables the company to continue leveraging strong Ontario science, as well as develop manufacturing and local career opportunities for scientists and trainees

Read More from FACIT Features: Fusion Pharma Attracts $20M USD Commitment from Canada Pension Plan Investment Board

FACIT Features: Turnstone Biologics Partners with Takeda on viral immunotherapies for cancer

December 19, 2019 – December 19, 2019 – The strategic collaboration will focus on developing multiple products from Turnstone’s next-gen oncolytic viral immunotherapies, marking an important alliance for both companies in the fight against cancer.

Read More from FACIT Features: Turnstone Biologics Partners with Takeda on viral immunotherapies for cancer

FACIT Features: OICR's Dr. Trevor Pugh wins $1M award for early cancer detection

December 5, 2019 – December 5, 2019 – The $1M award will support Dr. Pugh’s development work towards advancing a blood-based diagnostic for early cancer detection, in collaboration with Dr. Raymond Kim of the Princess Margaret Cancer Centre.

Read More from FACIT Features: OICR's Dr. Trevor Pugh wins $1M award for early cancer detection

FACIT, Triphase Accelerator, Celgene, and OICR to present at Canadian Science Policy Conference 2019

November 8, 2019 – November 8, 2019 – Titled “Ontario First in the innovation economy: impacts of a $1B USD public-private-partnership (PPP) on Canadian healthcare commercialization”, the panel seeks to highlight the outcomes and key lessons from this unprecedented partnership.

Read More from FACIT, Triphase Accelerator, Celgene, and OICR to present at Canadian Science Policy Conference 2019

FACIT launches assessment of venture philanthropy models to scale Canadian commercialization of cancer research

November 6, 2019 – November 6, 2019 – Scaling FACIT’s impact requires new partners and expanded expertise in the management of investments and equity markets. To that end, FACIT has recruited two seasoned executives through its Executive-in-Residence (EIR) Program.

Read More from FACIT launches assessment of venture philanthropy models to scale Canadian commercialization of cancer research

FACIT Features: Portfolio company KA Imaging secures Series A financing and new global strategic partner

October 24, 2019 – October 24, 2019 – New partnership will provide the Ontario-based start up with both capital and advanced manufacturing expertise to accelerate its portable multi-energy x-ray detector technology.

Read More from FACIT Features: Portfolio company KA Imaging secures Series A financing and new global strategic partner